Načítá se...
Era of biosimilars in rheumatology: reshaping the healthcare environment
Compared with the original approved biological drug on which it is based, a biosimilar has highly similar physicochemical characteristics and biological activity, as well as equivalent efficacy and no clinically meaningful differences in safety and immunogenicity. Before they are approved, biosimila...
Uloženo v:
| Vydáno v: | RMD Open |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6560670/ https://ncbi.nlm.nih.gov/pubmed/31245050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-000900 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|